Unique safe and biocompatible technologies which prevent medical device related infections

To champion a healthier world by preventing infections

Bactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine.

The company also has a portfolio of wound management products.


Bactiguard operates through license partnerships with leading global MedTech companies that apply the technology to their medical devices and sell them under their own brand or co-branded with Bactiguard.

Medical Devices

Bactiguard has a portfolio of coated medical devices which comprises of urinary catheters, endotracheal tubes, and central venous catheters.

Following a strategic review in 2023, the portfolio is currently being discontinued.

Wound Management

Bactiguard’s Wound Management offering includes Hydrocyn aqua (wound care products enabling wound healing and preventing infection) as well as a wide range of surgical sutures.

Prevent the risk of infection

Bactiguard’s BIP Foley catheters decrease the risk of catheter associated urinary tract infection by 69%.

Each year 1 of 10 patients are affected by healthcare associated infections, HAI, globally. The most common HAI is urinary tract infection and a large majority is caused by indwelling urinary catheters.

Prevent the risk of infection